13F filer · CIK 1920938
BRAIDWELL LP
STAMFORD, CT · filing since Q4 2022 · last filing Aug 14, 2026
Reported value
$2.7B
$-294.3M vs prior
Positions
86
New / sold out
24 / 26
Added / reduced
21 / 36
Turnover
19.4%
buys $554.3M · sells $1.4B
Top-10 weight
31.6%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | HUMANA INC | +114,500 | – | +$45.5M |
| Added | ALPHATEC HLDGS INC | +4,358,714 | +200.6% | +$37.7M |
| New | MAZE THERAPEUTICS INC | +1,140,040 | – | +$34.0M |
| New | AVALO THERAPEUTICS INC | +1,629,182 | – | +$30.1M |
| New | ALAMAR BIOSCIENCES INC | +1,083,983 | – | +$29.4M |
| New | ORUKA THERAPEUTICS INC | +278,164 | – | +$26.5M |
| New | AVALYN PHARMACEUTICALS INC | +801,395 | – | +$26.4M |
| Added | DAMORA THERAPEUTICS INC | +725,531 | +81.1% | +$18.9M |
| Added | TRANSMEDICS GROUP INC | +280,324 | +85.1% | +$18.6M |
| Added | REPLIGEN CORP | +129,600 | +272.8% | +$17.7M |
35 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | GUARDANT HEALTH INC | -60,954,000 | -100.0% | $-102.6M |
| Reduced | REPLIGEN CORP | -85,000,000 | -84.2% | $-87.4M |
| Sold out | CENTESSA PHARMACEUTICALS PLC | -1,986,768 | -100.0% | $-78.9M |
| Reduced | NEOGENOMICS INC | -82,370,000 | -82.1% | $-77.2M |
| Sold out | NUVALENT INC | -700,429 | -100.0% | $-71.8M |
| Sold out | CG ONCOLOGY INC | -984,783 | -100.0% | $-66.7M |
| Reduced | ARGENX SE | -67,232 | -79.2% | $-62.4M |
| Reduced | NEUROCRINE BIOSCIENCES INC | -315,950 | -48.4% | $-53.2M |
| Reduced | GUARDANT HEALTH INC | -351,862 | -70.4% | $-52.8M |
| Reduced | MBX BIOSCIENCES INC | -781,587 | -52.4% | $-43.1M |
52 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | CARIS LIFE SCIENCES INCCOM | 8,256,032 | $147.1M | 5.44% |
| 2 | HINGE HEALTH INCCL A | 1,330,127 | $110.4M | 4.08% |
| 3 | GLAUKOS CORPCOM | 591,927 | $82.7M | 3.06% |
| 4 | EDGEWISE THERAPEUTICS INCCOM | 1,996,965 | $81.1M | 3.00% |
| 5 | SPYRE THERAPEUTICS INCCOM NEW | 879,467 | $78.1M | 2.89% |
| 6 | IRHYTHM HOLDINGS INCCOM | 654,262 | $77.8M | 2.88% |
| 7 | NEOGENOMICS INCCOM NEW | 4,918,202 | $71.8M | 2.65% |
| 8 | KODIAK SCIENCES INCCOM | 1,787,318 | $69.6M | 2.58% |
| 9 | XENON PHARMACEUTICALS INCCOM | 1,131,452 | $68.3M | 2.53% |
| 10 | ALPHATEC HLDGS INCNOTE 0.750% 3/1 | 69,121,000 | $66.2M | 2.45% |
76 more rows. Subscribe for $29/month to see every row, download the data and use the API.